Philip Morris - PM STOCK NEWS

Philip Morris International (PMI) will host a live video webcast for its 2021 Investor Day on February 10, 2021, from 8:30 a.m. to 1:30 p.m. ET. Senior management will present and engage in a Q&A session, accessible via www.pmi.com/2021InvestorDay. An archive of the session will be available until March 11, 2021, at 5:00 p.m. ET. PMI is focused on creating a smoke-free future, encouraging adult smokers to transition to smoke-free products, including the IQOS platform, which has already helped approximately 11.7 million smokers switch.

Philip Morris International Inc. (PMI) has signed a memorandum of understanding with the U.S. Department of Homeland Security's National Intellectual Property Rights Coordination Center. This partnership aims to combat illicit tobacco trade and support investigations into intellectual property rights violations. PMI's head of illicit trade prevention emphasized the importance of this cooperation to disrupt criminal organizations profiting from this trade. The agreement builds on previous initiatives to enhance national security and protect consumers from illicit products.

Philip Morris International (NYSE: PM) will host a live audio webcast on February 4, 2021, at 10:30 a.m. ET to discuss its 2020 Fourth-Quarter and Full-Year results. The results will be disclosed at 8:00 a.m. ET the same day. CFO Emmanuel Babeau will present the financial outcomes and the 2021 outlook, with Q&A from the CEO and COO. The event will be accessible in listen-only mode, and an archived version will be available until March 5, 2021. PMI focuses on a smoke-free future, with 11.7 million adult smokers having switched to its IQOS product.

Philip Morris International (PMI) has appointed Jorge Insuasty as Chief Life Sciences Officer, effective January 15, 2021. Insuasty, who has extensive experience in the pharmaceutical industry, succeeds John O’Mullane, who is retiring. CEO André Calantzopoulos highlighted Insuasty's transformational leadership and his role in advancing product portfolios. Insuasty previously held significant positions at Sanofi and Novartis, leading successful drug approvals and innovations. PMI aims to create a smoke-free future by replacing traditional cigarettes with smoke-free alternatives, benefiting adult smokers.

Philip Morris International (NYSE:PM) will redeem all outstanding 1.875% Notes due February 25, 2021, on January 25, 2021. As of December 15, 2020, $750 million in principal was outstanding. PMI will pay the registered holders 100% of the principal amount plus accrued interest. This release does not constitute a notice of redemption. PMI is transitioning to a smoke-free future, encouraging adult smoking cessation with its IQOS product, which has moved approximately 11.7 million adults to smoke-free alternatives across 61 markets. For more, visit www.pmi.com.

Philip Morris International (PM) announced a leadership succession plan set to be finalized in May 2021. André Calantzopoulos will transition from CEO to Executive Chairman, while Jacek Olczak will become the new CEO. This change follows Mr. Louis Camilleri's retirement as Chairman. The transition aims for continuity in leadership, highlighting the company’s strategic vision and achievements in smoke-free product development. Olczak, with extensive experience in the company, is expected to drive future innovation and shareholder value.

The Board of Directors of Philip Morris International (NYSE: PM) has declared a quarterly dividend of $1.20 per common share, payable on January 11, 2021, to shareholders on record as of December 23, 2020. The ex-dividend date is December 22, 2020. PMI is committed to transforming the tobacco industry towards a smoke-free future, aiming to replace traditional cigarettes with innovative smoke-free products, such as the IQOS device, which has attracted over 11.7 million adult smokers globally.

Philip Morris International (PM) has received commendations from CDP and Science Based Targets initiative (SBTi) for its sustainability initiatives. PMI is among only 10 companies globally to achieve a 'Triple A' from CDP over its climate change and water security efforts. Furthermore, SBTi has verified PMI's emissions targets, aligning them with the Paris Agreement goals. CEO André Calantzopoulos emphasized their commitment to sustainability, aiming for carbon neutrality in direct operations by 2030 and across the value chain by 2050. PMI's dedication to reducing environmental impact is highlighted through various strategic programs.

The FDA has authorized the sale of Philip Morris International's IQOS 3, an advanced electrically heated tobacco system, citing it as beneficial for public health. This decision follows a premarket tobacco product application submitted in March 2020. IQOS 3 features improved battery life and faster recharge times. The FDA reported no increased usage among youth and young adults. PMI's CEO stated that this approval could accelerate the transition from smoking to less harmful alternatives. The authorization is in line with previous PMTA orders aimed at minimizing unintended use among youth.